Verona Pharma Plc ADR (NASDAQ:VRNA) currently has a daily average trading volume of 1.36M but it saw 1457598 shares traded in last market. With a market cap of 6.60B USD, the company’s current market price of $77.49 came rising about 4.82 while comparing to the previous closing price of $73.93. In past 52 weeks, the stock remained buoying in the range of price level as high as $76.92 and as low as $11.39.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the TD Cowen which initiated the stock as “Buy” in its note to investors issued on April 28, 2025, recommending a price target of $100 for it. ROTH MKM also issued its recommendations for the stock as it initiated the price target for the stock is $68.
Over the week, VRNA’s stock price is moving 4.59% up while it is 5.84% when we observe its performance for the past one month. Year-to-date it is 66.86% up and over the past year, the stock is showing an upside performance of 543.60%.
Currently, Verona Pharma Plc ADR’s total number of outstanding shares is 85.13M with 11.95% of that held by the insiders while 90.84% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -34.98% and return on equity (ROE) at -72.73%. It has a 71.60 of forward P/E ratio. Stock’s beta reads 0.17. Stock has a price to book (P/B) ratio of 29.11 while price to sale or P/S ratio amounts to 55.65. Its return on asset (ROA) is -40.26% on average.
